Influence of phospholipid-containing additives on the functional condition of organs and systems of mice
DOI:
https://doi.org/10.31548/ujvs2020.03.002Ключові слова:
milk phospholipids, BAA "FLP-MD", laboratory mice of the CBA line, clinical, hematological and microscopic examinations, functional state of the organismАнотація
Abstract. Numerous studies in experiments on laboratory animals and in clinical practice have confirmed the positive effect of essential phospholipids on the structural organization of cell membranes, intracellular metabolism, mitochondrial function, antioxidant processes, which explains the active use of phospholipid-containing drugs in hepato- and enteropathologies, cardiovascular diseases, etc. Raw material of animal origin, in particular milk, which is a safe source of biologically active substances, has a structural similarity with phospholipids of mammalian tissues. Based on them, a biologically active additive (BAA) "FLP-MD" was created, which is characterized by membraneotropic properties and reparative effect. The aim of work was to investigate the biological effect of the liposomal form of BAA "FLP-MD" based on milk phospholipids on the body of clinically healthy laboratory mice.
Determination of the toxicity of phospholipid-containing BAA "FLP-MD" was performed on mice of the CBA line. The duration of the experiment was 16 days. The results of the studies indicate a probable increase in body weight of mice of the CBA line after the 10th day of intragastric administration of 1% solution of liposomal form of BAA "FLP-MD".
As a result of the study of biochemical parameters of plasma / native blood, the absence of toxic effects of liposomal form of BAA "FLP-MD" on the functional state of the body of mice was set. Morphological parameters of peripheral blood in these animals did not change significantly. According to the results of microscopic studies, no negative effect of the liposomal form of BAA "FLP-MD" on the structure microstructure of the mucous membrane of the gastrointestinal tract was found.
Therefore, the components of BAA "FLP-MD" do not adversely affect the functional state of organs and systems of laboratory mice and do not show a toxic effect, which allows it to be recommended for use in veterinary medicine as a means of rehabilitation therapy.
Keywords: milk phospholipids, BAA "FLP-MD", laboratory mice of the CBA line, clinical, hematological and microscopic examinations, functional state of the organism
Посилання
Bothra, A., Arumugam, P., Panchal, V., Menon, D., Srivastava, S., Shankaran, D., Nandy, A., Jaisinghani, N., Singh, A., Gokhale, R. S., Gandotra S., & Rao V. (2018). Phospholipid homeostasis, membrane tenacity and survival of Mtb in lipid rich conditions is determined by MmpL11 function. Scientific Reports, 8(8317):1-14.
https://doi.org/10.1038/s41598-018-26710-z
Calitz, C., Hamman, J. H., Fey, S. J., Wrzesinski, K., & Gouws, C. (2018). Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective. Toxicology Mechanisms and Methods, 28(5):369-385.
https://doi.org/10.1080/15376516.2017.1422580
Colombo, S., Melo, T., Martinez-Lopez, M., Carrasco, M. J., Domingues, P., Pérez-Sala, D., & Domingues, R. (2018). P-150 - Phospholipidome of endothelial cells shows a different adaptation response upon oxidative, glycative or carbonyl stress. Free Radical Biology and Medicine, 120(1):S90. https://doi.org/10.1016/j.freeradbiomed.2018.04.297
Gariani, K., Ryu, D., Menzies, K. J., Yi, H.-S., Stein, S., Zhang, H., Perino, A., Lemos, V., Katsyuba, E., Jha, P., Vijgen, S., Rubbia-Brandt, L., Kim, Y. K., Kim, J. T., Kim, K. S., Shong, M., Schoonjans, K., & Auwerx1, J. (2017). Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. Journal of Hepatology, 66(1):132-141. https://doi.org/10.1016/j.jhep.2016.08.024
Gryshchenko, V. A. (2019). Blood and acid composition of blood and biles in calves at enteropatology and application of milk phospholipides. Ukrainian Journal of Veterinary Sciences, 10(4): 36-42.
https://doi.org/10.31548/ujvs2019.04.005
Gryshchenko V., Danchenko O., & Musiychuk V. (2019) Modification of Modeling Method of Toxic Dystrophy of Liver in Rats. In: Nadykto V. (eds) Modern Development Paths of Agricultural Production. Springer, Cham.
https://doi.org/10.1007/978-3-030-14918-5_67
Gryshchenko V. А., Sуsolyatin S. V., & Gulevata J. V. (2018). Phospholipid composition of blood plasma and internal organs of rats with diclofenac-induced hepatitis. Ukrainian Journal of Ecology, 8(3): 211-215.
Gryshchenko, V., Sуsoliatin, S., & Midyk, S. (2019). Fatty acids of lipids of blood serum and liver of rats with tetracyclin-induced hepatosis and at correction. Regulatory Mechanisms in Biosystems, 10(4):520-525.
https://doi.org/10.15421/021976
Gula, N. M., & Margitich, V. M. (2009). Zhyrni kysloty ta yikh pokhidni pry patolohichnykh stanakh [Fatty acids and their derivatives in pathologic starts]. Naukova dumka, Kyiv (in Ukrainian).
Melnychuk, D. O., Gryshchenko, V. A., & Lytvynenko, O. N.: Veterynarna biologichno aktyvna dobavka liposomal'noi' formy ta sposib reparatyvnoi' terapii' v gepatologii' [Veterinary biologically active additive of liposomal form and method of reparative therapy in hepatology]. Patent UA, 86516 (2009). (in Ukrainian).
Sang-Chul, K. & Xuemin, W. (2020). Phosphatidic acid: an emerging versatile class of cellular mediators . Essays in Biochemistry. EBC20190089. https://doi.org/10.1042/EBC20190089
Solís-Calero, C., Ortega-Castro, J., Frau, J. & Muñoz, F (2015). Nonenzymatic reactions above phospholipid surfaces of biological membranes: reactivity of phospholipids and their oxidation derivatives. Oxidative Medicine and Cellular Longevity, 319505:22.
https://doi.org/10.1155/2015/319505
Starr, M. L., Sparks, R. P., Arango, A. S., Hurst, L. R., Zhao, Z., Lihan, M., Jenkins, J. L. Tajkhorshid, E., & Fratti, R. A. (2019). Phosphatidic acid induces conformational changes in Sec18protomers that prevent SNARE priming. Journal of Biological Chemistry, 294:3100-3116.
https://doi.org/10.1074/jbc.RA118.006552
Tomchuk V., Gryshchenko, V., Vlizlo, V., & Enciu V. (2019). Сorrective effect of milk phospholipids in pathological conditions. Iaşi Editura Ion Ionescu de la Brad.
Udut, V. V., Vengerovsky, A. I., & Dygai, A. M. (2013). Effects of phospholipid hepatoprotectors on apoptosis during experimental liver pathology induced by isoniazid and paracetamol. Bulletin of Experimental Biology and Medicine, 154(5):614-617.
https://doi.org/10.1007/s10517-013-2012-9
Vlizlo, V. V., Fedoruk, R. S., & Ratych, I. B. (2012). Laboratorni metody doslidzhen u biolohiyi, tvarynnytstvi ta veterynarniy medytsyni [Laboratory methods of investigation in biology, stock-breeding and veterinary]. Spolom, Lviv (in Ukrainian).
Yang, K. J., Son, J., Jung, S. Y., Yi, G., Yoo, J., Kim, D. K., & Koo, H. (2018). Optimized phospholipid-based nanoparticles for inner ear drug delivery and therapy. Biomaterials, 171(7):133-143.
https://doi.org/10.1016/j.biomaterials.2018.04.038
Zhang, X., Yang, L., Liu, Y., Song, Z., Zhao, J., Chen, D., Yu, H., Li, R., Wang, Y., Yang, K., Chen, Y., Xia, M., & Zhang, L. W. (2018). Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis. Toxicology and Applied Pharmacology, 348:54-66.
Завантаження
Опубліковано
Номер
Розділ
Ліцензія
Стосунки між правовласниками і користувачами регулюються на умовах ліцензії Creative Commons Із Зазначенням Авторства – Некомерційна – Поширення На Тих Самих Умовах 4.0 Міжнародна (CC BY-NC-SA 4.0):https://creativecommons.org/licenses/by-nc-sa/4.0/deed.uk
Автори, які публікуються у цьому журналі, погоджуються з наступними умовами:
- Автори залишають за собою право на авторство своєї роботи та передають журналу право першої публікації цієї роботи на умовах ліцензії Creative Commons Attribution License, котра дозволяє іншим особам вільно розповсюджувати опубліковану роботу з обов'язковим посиланням на авторів оригінальної роботи та першу публікацію роботи у цьому журналі.
- Автори мають право укладати самостійні додаткові угоди щодо неексклюзивного розповсюдження роботи у тому вигляді, в якому вона була опублікована цим журналом (наприклад, розміщувати роботу в електронному сховищі установи або публікувати у складі монографії), за умови збереження посилання на першу публікацію роботи у цьому журналі.
- Політика журналу дозволяє і заохочує розміщення авторами в мережі Інтернет (наприклад, у сховищах установ або на особистих веб-сайтах) рукопису роботи, як до подання цього рукопису до редакції, так і під час його редакційного опрацювання, оскільки це сприяє виникненню продуктивної наукової дискусії та позитивно позначається на оперативності та динаміці цитування опублікованої роботи (див.The Effect of Open Access).
